Steven Ryder serves as Executive at REATA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Steven Ryder has executed 6 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 26, 2023 involved selling 10,907 shares valued at $0.
Steven Ryder currently holds 9,225 shares of REATA PHARMACEUTICALS INC (RETA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Steven Ryder has been a net neutral trader of RETA stock. They have purchased $0 and sold $0 worth of shares.
Steven Ryder's most recent insider trade was on Sep 26, 2023, when they sold 10,907 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $93.61 |
| Discretionary |
| Jun 7, 2023 | RETA | $157.5K | Award | 1,682 | $93.61 | Discretionary |
| Jul 11, 2022 | RETA | $29.5K | Award | 913 | $32.36 | Discretionary |
| Jul 11, 2022 | RETA | $122.8K | Award | 3,794 | $32.36 | Discretionary |
| Jul 11, 2022 | RETA | $135.0K | Award | 4,171 | $32.36 | Discretionary |